Literature DB >> 26901574

Rapid improvements in pain and quality of life are sustained after surgery for spinal metastases in a large prospective cohort.

David Choi1, Zoe Fox1, Todd Albert2,3, Mark Arts4, Laurent Balabaud5, Cody Bunger6, Jacob Maciej Buchowski7, Maarten Hubert Coppes8, Bart Depreitere9, Michael George Fehlings10, James Harrop2,3, Norio Kawahara11, Juan Anthonio Martin-Benlloch12, Eric Maurice Massicotte10, Christian Mazel5, Fetullah Cumhur Oner13, Wilco Peul3,14, Nasir Quraishi15, Yasuaki Tokuhashi16, Katsuro Tomita17, Jorit Jan Verlaan13, Miao Wang6, Michael Wang18, Hugh Alan Crockard1.   

Abstract

Introduction Metastatic spinal cancer is a common condition that may lead to spinal instability, pain and paralysis. In the 1980s, surgery was discouraged because results showed worse neurological outcomes and pain compared with radiotherapy alone. However, with the advent of modern imaging and spinal stabilisation techniques, the role of surgery has regained centre stage, though few studies have assessed quality of life and functional outcomes after surgery. Objective We investigated whether surgery provides sustained improvement in quality of life and pain relief for patients with symptomatic spinal metastases by analysing the largest reported surgical series of patients with epidural spinal metastases. Methods A prospective cohort study of 922 consecutive patients with spinal metastases who underwent surgery, from the Global Spine Tumour Study Group database. Pre- and post-operative EQ-5D quality of life, visual analogue pain score, Karnofsky physical functioning score, complication rates and survival were recorded. Results Quality of life (EQ-5D), VAS pain score and Karnofsky physical functioning score improved rapidly after surgery and these improvements were sustained in those patients who survived up to 2 years after surgery. In specialised spine centres, the technical intra-operative complication rate of surgery was low, however almost a quarter of patients experienced post-operative systemic adverse events. Conclusion Surgical treatment for spinal metastases produces rapid pain relief, maintains ambulation and improves good quality of life. However, as a group, patients with cancer are vulnerable to post-operative systemic complications, hence the importance of appropriate patient selection.

Entities:  

Keywords:  Metastasis; outcome; quality of life; spine; surgery

Mesh:

Year:  2016        PMID: 26901574     DOI: 10.3109/02688697.2015.1133802

Source DB:  PubMed          Journal:  Br J Neurosurg        ISSN: 0268-8697            Impact factor:   1.596


  19 in total

1.  Patient-reported outcomes after surgical stabilization of spinal tumors: symptom-based validation of the Spinal Instability Neoplastic Score (SINS) and surgery.

Authors:  Ibrahim Hussain; Ori Barzilai; Anne S Reiner; Natalie DiStefano; Lily McLaughlin; Shahiba Ogilvie; Mark Bilsky; Ilya Laufer
Journal:  Spine J       Date:  2017-07-13       Impact factor: 4.166

2.  Quality of life, pain, and psychological factors in patients undergoing surgery for primary tumors of the spine.

Authors:  Francesca Luzzati; Emanuele Maria Giusti; Gennaro Maria Scotto; Giuseppe Perrucchini; Luca Cannavò; Gianluca Castelnuovo; Andrea Colonna Cottini
Journal:  Support Care Cancer       Date:  2019-07-01       Impact factor: 3.603

3.  Does surgical site infection influence neurological outcome and survival in patients undergoing surgery for metastatic spinal cord compression?

Authors:  N A Quraishi; M S Ahmed; G Arealis; B M Boszczyk; K L Edwards
Journal:  Eur Spine J       Date:  2018-10-27       Impact factor: 3.134

4.  Outcomes of surgical treatments of spinal metastases: a prospective study.

Authors:  C Bouthors; S Prost; C Court; B Blondel; Y P Charles; S Fuentes; H P Mousselard; C Mazel; C H Flouzat-Lachaniette; P Bonnevialle; F Saihlan
Journal:  Support Care Cancer       Date:  2019-08-09       Impact factor: 3.603

Review 5.  Diagnosis and treatment of epidural metastases.

Authors:  S A Grossman; D Lossignol
Journal:  Oncology (Williston Park)       Date:  1990-04       Impact factor: 2.990

6.  Survival, local control, and health-related quality of life in patients with oligometastatic and polymetastatic spinal tumors: A multicenter, international study.

Authors:  Ori Barzilai; Anne L Versteeg; Arjun Sahgal; Laurence D Rhines; Mark H Bilsky; Daniel M Sciubba; James M Schuster; Michael H Weber; Peter Pal Varga; Stefano Boriani; Chetan Bettegowda; Michael G Fehlings; Yoshiya Yamada; Michelle J Clarke; Paul M Arnold; Ziya L Gokaslan; Charles G Fisher; Ilya Laufer
Journal:  Cancer       Date:  2018-11-29       Impact factor: 6.860

7.  Do Cohabitants Reliably Complete Questionnaires for Patients in a Terminal Cancer Stage when Assessing Quality of Life, Pain, Depression, and Anxiety?

Authors:  Olivier Q Groot; Nuno Rui Paulino Pereira; Michiel E R Bongers; Paul T Ogink; Erik T Newman; Jorrit-Jan Verlaan; Kevin A Raskin; Santiago A Lozano-Calderon; Joseph H Schwab
Journal:  Clin Orthop Relat Res       Date:  2021-04-01       Impact factor: 4.176

8.  A Natural History of Patients Treated Operatively and Nonoperatively for Spinal Metastases Over 2 Years Following Treatment: Survival and Functional Outcomes.

Authors:  Grace X Xiong; Miles W A Fisher; Joseph H Schwab; Andrew K Simpson; Lananh Nguyen; Daniel G Tobert; Tracy A Balboni; John H Shin; Marco L Ferrone; Andrew J Schoenfeld
Journal:  Spine (Phila Pa 1976)       Date:  2022-04-01       Impact factor: 3.468

9.  The Cost-Effectiveness of Surgical Intervention for Spinal Metastases: A Model-Based Evaluation.

Authors:  Andrew J Schoenfeld; Gordon P Bensen; Justin A Blucher; Marco L Ferrone; Tracy A Balboni; Joseph H Schwab; Mitchel B Harris; Jeffrey N Katz; Elena Losina
Journal:  J Bone Joint Surg Am       Date:  2021-07-21       Impact factor: 5.284

10.  Hybrid surgery-radiosurgery therapy for metastatic epidural spinal cord compression: A prospective evaluation using patient-reported outcomes.

Authors:  Ori Barzilai; Mary-Kate Amato; Lily McLaughlin; Anne S Reiner; Shahiba Q Ogilvie; Eric Lis; Yoshiya Yamada; Mark H Bilsky; Ilya Laufer
Journal:  Neurooncol Pract       Date:  2017-07-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.